RIN Institute

About:

RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.

Website: https://rinmab.co.jp

Top Investors: Mitsubishi UFJ Capital, UTokyo Innovation Platform, Fast Track Initiative, Inc.

Description:

RIN Institute is a R & D of antibody-based drugs and in vitro diagnostic drugs.

Total Funding Amount:

401M JPY

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2016-01-21

Founders:

Matsumura Yasuhiro

Number of Employees:

101-250

Last Funding Date:

2021-07-02

IPO Status:

Private

Industries: